tavr prostheses sapien xt  (CoreValve Inc)

Journal: JACC Case Reports

Article Title: Mitral Transcatheter Edge-to-Edge Repair for Anterior Leaflet Flail Induced by Transapical Transcatheter Aortic Valve Replacement

doi: 10.1016/j.jaccas.2025.104653

Figure Lengend Snippet: Antegrade Crossing of the Aortic Valve by the TAVR Delivery System

Article Snippet: TAVR device • 26 mm Sapien 3 Ultra valve (Edwards Lifesciences, USA) , Mitral TEER device • MitraClip G4 system (steerable guide catheter [SGC] and clip delivery system [CDS]), XT clip (Abbott Structural Heart, USA).

Techniques:

Journal: JACC Case Reports

Article Title: Mitral Transcatheter Edge-to-Edge Repair for Anterior Leaflet Flail Induced by Transapical Transcatheter Aortic Valve Replacement

doi: 10.1016/j.jaccas.2025.104653

Figure Lengend Snippet: Implantation of the Edwards Sapien 3 Ultra Valve

Article Snippet: TAVR device • 26 mm Sapien 3 Ultra valve (Edwards Lifesciences, USA) , Mitral TEER device • MitraClip G4 system (steerable guide catheter [SGC] and clip delivery system [CDS]), XT clip (Abbott Structural Heart, USA).

Techniques:

Journal: JACC Case Reports

Article Title: Mitral Transcatheter Edge-to-Edge Repair for Anterior Leaflet Flail Induced by Transapical Transcatheter Aortic Valve Replacement

doi: 10.1016/j.jaccas.2025.104653

Figure Lengend Snippet: Timeline of MR Evolution Three-chamber view on transesophageal echocardiography illustrating the evolution of mitral regurgitation (MR) at 3 key time points. (A) Baseline, pre-transcatheter aortic valve replacement (TAVR): none/trivial MR. (B) Immediately post-TAVR: trivial MR. (C) 2-month follow-up after TAVR: severe primary MR.

Article Snippet: TAVR device • 26 mm Sapien 3 Ultra valve (Edwards Lifesciences, USA) , Mitral TEER device • MitraClip G4 system (steerable guide catheter [SGC] and clip delivery system [CDS]), XT clip (Abbott Structural Heart, USA).

Techniques:

Journal: Annals of Cardiothoracic Surgery

Article Title: Transcatheter versus surgical aortic valve replacement in low- to intermediate-risk patients: a meta-analysis of reconstructed time-to-event data

doi: 10.21037/acs-2024-etavr-0096

Figure Lengend Snippet: Study profiles and patient characteristics

Article Snippet: Sensitivity analyses were conducted by (I) only incorporating studies with a follow-up period exceeding 1 year; (II) only incorporating studies with >50% use of the current generation of TAVR devices (SAPIEN 3: Edwards Lifesciences, Irvine, CA, USA; and Evolut R, Evolut PRO: Medtronic, Minneapolis, MN, USA).

Techniques:

Journal: Annals of Cardiothoracic Surgery

Article Title: Transcatheter versus surgical aortic valve replacement in low- to intermediate-risk patients: a meta-analysis of reconstructed time-to-event data

doi: 10.21037/acs-2024-etavr-0096

Figure Lengend Snippet: Kaplan-Meier analysis of (A) all-cause mortality and (B) composite outcome of all-cause mortality and disabling stroke. HR, hazard ratio; CI, confidence interval; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.

Article Snippet: Sensitivity analyses were conducted by (I) only incorporating studies with a follow-up period exceeding 1 year; (II) only incorporating studies with >50% use of the current generation of TAVR devices (SAPIEN 3: Edwards Lifesciences, Irvine, CA, USA; and Evolut R, Evolut PRO: Medtronic, Minneapolis, MN, USA).

Techniques:

Journal: Annals of Cardiothoracic Surgery

Article Title: Transcatheter versus surgical aortic valve replacement in low- to intermediate-risk patients: a meta-analysis of reconstructed time-to-event data

doi: 10.21037/acs-2024-etavr-0096

Figure Lengend Snippet: Kaplan-Meier analysis of (A) heart failure rehospitalization rate and (B) disabling stroke rate. HR, hazard ratio; CI, confidence interval; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.

Article Snippet: Sensitivity analyses were conducted by (I) only incorporating studies with a follow-up period exceeding 1 year; (II) only incorporating studies with >50% use of the current generation of TAVR devices (SAPIEN 3: Edwards Lifesciences, Irvine, CA, USA; and Evolut R, Evolut PRO: Medtronic, Minneapolis, MN, USA).

Techniques:

Journal: Annals of Cardiothoracic Surgery

Article Title: Transcatheter versus surgical aortic valve replacement in low- to intermediate-risk patients: a meta-analysis of reconstructed time-to-event data

doi: 10.21037/acs-2024-etavr-0096

Figure Lengend Snippet: Landmark analysis at 1 year of (A) all-cause mortality and (B) composite outcome of all-cause mortality and disabling stroke. HR, hazard ratio; CI, confidence interval; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.

Article Snippet: Sensitivity analyses were conducted by (I) only incorporating studies with a follow-up period exceeding 1 year; (II) only incorporating studies with >50% use of the current generation of TAVR devices (SAPIEN 3: Edwards Lifesciences, Irvine, CA, USA; and Evolut R, Evolut PRO: Medtronic, Minneapolis, MN, USA).

Techniques: